ArticleNeuro-oncology practice2019

Seizure response to temozolomide chemotherapy in patients with WHO grade II oligodendroglioma: a single-institution descriptive study.

Aya Haggiagi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.